Cangzhou, Hebei, China
Response Time: < 24h
Response Rate: 0%
Model No.: 09 | Place of Origin: China |
Items | Standard | |
Appearance and smell | White fine needle crystal or white crystalline powder; odorless or almost odorless | |
Solubility | Freely soluble in ethanol or ether, soluble in boiling water, sparingly soluble in chloroformslightly soluble in water | |
Melting point | 158~161 ℃ | |
Identification (1) Color reaction | Violet color is produce | |
Identification(2)IR-Spectrum | Should be complied with Reference Spectrum (Spectral set 57) | |
Residue on ignition | ≤0.1% | |
Heavy metals | ≤10 ppm | |
Related substances | 4-hydroxybenzoic acid | ≤0.1% |
4-hydroxyisophthalic acid | ≤0.05% | |
Phenol | ≤0.02% | |
Other impurities | ≤0.05% | |
Total impurities | ≤0.2% | |
Assay | ≥99.5% |
Hebei Jingye Medical Technology Co., Ltd. is a high-tech pharmaceutical company based in China for the world. With a clear focus on the manufacture, research and development and providing services for cardiovascular and cerebrovascular preparations and bulk pharmaceutical chemicals, the company is committed to emerging to be the most competitive manufacturer of salicylic acid and aspirin. It owns 4 varieties of products and 6 others in stock, all of which belong to preparations and bulk chemicals for cardiovascular and cerebrovascular diseases with great market prospects.Jingye Group, its parent company, is home to 22,500 employees with a total assets of 39 billion yuan. In 2018, Jingye Group registered 90.1 billion yuan in sales revenue and contributed 3.35 billion yuan in taxation. It ranks 251 on the list of Top 500 Chinese Enterprises and 110 on the list of Top 500 Chinese Manufacturing Enterprises, and tops the list of Top 100 enterprises in Shijiazhuang for 10 years in a row.
Founded in 1990, Jingye Medical Technology Co., Ltd. boasts advanced equipment, sophisticated technology and competent technical force. Owning to 28 years of unremitting efforts, the company has built its main products, Jingye-branded salicylic acid, medicinal salicylic acid and aspirin, to become well-known across the globe. Holding import & export licensees at hand, the company sells its products not only at home but also abroad. Its products enjoys 70% market share in China, and can be easily seen in the US, Russia, Britain, Germany, France and other European and American countries and a large number of Asian countries and regions.
To make the pharmaceutical sector larger and more competitive, the company selected the Bioengineering and Pharmaceutical Industrial Park in Bohai New District of Cangzhou, a national technology development zone, as the location for its new plant. Covering an area of up to100 mu, the new facility is designed by Tianjin Pharmaceuticals Design Institute with a total investment of 350 million yuan.